New requirements for medicine registration in the EU will improve global data exchange between pharmaceutical companies and regulatorsJune 14, 2021
Participation in the CPhI Worldwide 2018
Our company had the pleasure to participate in the world’s largest pharmaceutical exhibition, CPhI Worldwide on 9-11 October 2018 in Madrid.
For the first time in our history, we were honored to participate in such a large-scale worldwide exhibition. Our Member of the board Dr. Polina Dombure made a presentation about "CIS Market: Regulatory Strategies in Dynamic Convergence", also including a presentation about Prudenta, a solution for monitoring adverse drug reactions in the local medical literature.
CPhI Worldwide houses six individual pharma events covering all industry sectors. We can not disagree that CPhI is uniting over 45,000 pharma professionals from around the globe and more than 2,500 international exhibitors and it is the place to network and source cost-effective pharma solutions from all over the world. In just three days under one roof, we had a chance to connect & network with international exhibitors and pharma professionals.
See you in Frankfurt next time!
Новые требования к подаче сведений при регистрации лекарственных средств в Евросоюзе улучшат глобальный обмен данными между фармкомпаниями и регуляторамиJune 10, 2021
Inpharmatis принял участие в работе ПМЭФ-2021June 04, 2021
Ольга Звонарева возглавит в Inpharmatis направление Regulatory Affairs в России и странах СНГMay 31, 2021
Inpharmatis appoints new RA Director in Russia & CISMay 31, 2021
Приведение досье в соответствие с правилами ЕАЭСMay 27, 2021
Bringing the dossier in accordance with the rules of the EAEUMay 27, 2021
Inpharmatis и «АКАДЕМФАРМ» обсудили в Минске перспективы сотрудничестваMay 21, 2021
Inpharmatis and “ACADEMPHARM” discussed in Minsk cooperation opportunitiesMay 21, 2021
Participation in IPhEB Russia 2021April 19, 2021